This model is of proven relevance to cardiometabolic disease and provides a probe for the study of therapeutic and genomic influences on inflammatory effects in these disorders.17, 32–33 Abundant evidence links Toll-like receptor-4 signaling and subsequent activation of innate immunity with the pathogenesis of insulin resistance and atherosclerosis. Here, TLR4 is linked to Insulin resistance.